CREBBP and hepatocellular carcinoma: Moreover, specific inhibition of CREB-binding protein (CBP), a coactivator of β-catenin/TCF-mediated transcription [145], also suppressed CD133 expression at both the mRNA and protein levels in hepatocellular carcinoma cells, reducing the anchorage-independent growth and colony formation capacity of these cells [146].